| NPA-NIHHDP | National Pituitary Agency-National Institutes of Health Hormone Distribution Program |
|---|---|
| PA | panic attack; pantothenic acid; paralysis agitans; paranoia; passive aggressive; pathology; patient'... |
| PACAP | pituitary adenylate cyclase activating polypeptide |
| PATH | pathology, pathological; pituitary adrenotropic hormone; physicians at teaching hospitals |
| PG | paregoric; parotid gland; pentagastrin; pepsinogen; peptidoglycan; Pharmacopoeia Germanica; phosphat... |
| diabetes mellitus | <disease> Relative or absolute lack of insulin leading to uncontrolled carbohydrate metabolism. In juvenile onset diabetes (that may be an autoimmune response to pancreatic _ cells) the insulin deficiency tends to be almost total, whereas in adult onset diabetes there seems to be no immunological component but an association with obesity. (18 Nov 1997) |
|---|---|
| diabetes mellitus, experimental | Diabetes mellitus induced experimentally by administration of various diabetogenic agents or by pancreatectomy. (12 Dec 1998) |
| diabetes mellitus, insulin-dependent | Diabetes mellitus characterised by insulin deficiency, sudden onset, severe hyperglycaemia, rapid progression to ketoacidosis, and death unless treated with insulin. The disease may occur at any age, but is most common in childhood or adolescence. (12 Dec 1998) |
| diabetes mellitus, lipoatrophic | A disorder characterised by complete absence of subcutaneous adipose tissue, insulin-resistant diabetes with little tendency to ketoacidosis, hyperlipidemia with subcutaneous xanthomatosis, hepatomegaly, and an elevated basal metabolic rate. (12 Dec 1998) |
| diabetes mellitus, non-insulin-dependent | Diabetes characterised by the ability to survive without ketoacidosis in the absence of insulin therapy. It is usually of slow onset and patients exhibit a tendency to obesity. (12 Dec 1998) |
| diabetes related peptide | <hormone, protein> Peptide of 37 amino acids that selectively inhibits insulin stimulated glucose uptake in muscle. Structurally related to calcitonin gene-related peptide. (15 Oct 1997) |
| diabetes, type 1 | Insulin dependent diabetes or juvenile diabetes. (12 Dec 1998) |
| diabetes, type 2 | Non-insulin dependent diabetes, adult-onset diabetes or insulin-resistant diabetes. (12 Dec 1998) |
| insulin dependent diabetes | A form of diabetes that requires the daily injection of the hormone insulin to maintain normal body chemistry. Avoidance of insulin in these patients will result in a severe metabolic derangement known as diabetic ketoacidosis. (27 Sep 1997) |
| insulin-dependent diabetes mellitus | A chronic condition in which the pancreas makes little or no insulin because the beta cells have been destroyed. The body is then not able to use the glucose (blood sugar) for energy. IDDM usually comes on abruptly, although the damage to the beta cells may begin much earlier. The signs of IDDM are a great thirst, hunger, a need to urinate often, and loss of weight. To treat the disease, the person must inject insulin, follow a diet plan, exercise daily, and test blood glucose several times a day. IDDM usually occurs in children and adults who are under age 30. This type of diabetes used to be known as juvenile diabetes, juvenile-onset diabetes, and ketosis-prone diabetes. (09 Oct 1997) |
| insulinopenic diabetes | Any form of diabetes mellitus resulting from inadequate secretion of insulin. (05 Mar 2000) |
| thiazide diabetes | Impaired carbohydrate metabolism associated with the use of thiazide diuretic drugs; severe manifestations are seen in persons having diabetes mellitus, but impairment is mild or absent in nondiabetic individuals. (05 Mar 2000) |
| type 1 diabetes | <endocrinology> Also referred to as juvenile onset diabetes. Underlying cause is likely genetic. Usually treated with daily insulin dosing. Insulin is necessary for the body to properly utilise glucose. Without insulin, glucose accumulates in the bloodstream. (27 Sep 1997) |
| type 2 diabetes | <endocrinology> Also referred to as adult-onset diabetes. More common in the middle-age, overweight individual. Usually treated by diet control, weight reduction or oral hypoglycemic agents. (27 Sep 1997) |
| type I diabetes | A chronic condition in which the pancreas makes little or no insulin because the beta cells have been destroyed. The body is then not able to use the glucose (blood sugar) for energy. IDDM usually comes on abruptly, although the damage to the beta cells may begin much earlier. The signs of IDDM are a great thirst, hunger, a need to urinate often, and loss of weight. To treat the disease, the person must inject insulin, follow a diet plan, exercise daily, and test blood glucose several times a day. IDDM usually occurs in children and adults who are under age 30. This type of diabetes used to be known as juvenile diabetes, juvenile-onset diabetes, and ketosis-prone diabetes. (09 Oct 1997) |